Article 1: "Quaternary ammonium compounds as potential antiviral agents for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)" 
Researchers investigated the effectiveness of quaternary ammonium compounds (QACs) as antiviral agents against SARS-CoV-2. They found that certain QACs exhibited strong antiviral activity against the virus by disrupting its lipid envelope, thus inhibiting viral entry and replication. The study suggests that QACs could be a promising avenue for developing antiviral treatments for COVID-19.

Article 2: "Efficacy of quaternary ammonium compounds (QACs) against Methicillin-Resistant Staphylococcus aureus (MRSA) biofilms"
This research focused on the efficacy of QACs in combating MRSA biofilms, which are notoriously resistant to traditional antibiotics. The study found that QACs were able to effectively disrupt MRSA biofilms, leading to a significant reduction in bacterial load. The findings suggest that QACs could be a valuable tool in the fight against antibiotic-resistant infections like MRSA.

Summary:
Research has shown that quaternary ammonium compounds (QACs) have promising antiviral and antibacterial properties. Studies have demonstrated that certain QACs can effectively combat SARS-CoV-2 by disrupting its lipid envelope and inhibiting viral replication. Additionally, QACs have shown efficacy in combating MRSA biofilms, which are highly resistant to traditional antibiotics. These findings suggest that QACs could be valuable in developing treatments for viral infections like COVID-19 and bacterial infections like MRSA.